Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APGE

Apogee Therapeutics Inc

May 11 • 04:00PM ET

84.60

+1.57 1.89 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: ARQT ANAB KYMR NRIX IMVT

| Held by: VTI XBI IWM TCAF VXF IWO IBB SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.33	Insider Own	25.45%	Shs Outstand	75.34M	Perf Week	1.26%
Market Cap	6.37B	Forward P/E	-	EPS next Y	-5.41	Insider Trans	-9.40%	Shs Float	56.17M	Perf Month	-1.94%
Enterprise Value	5.32B	PEG	-	EPS next Q	-1.06	Inst Own	88.61%	Short Float	16.89%	Perf Quarter	36.17%
Income	-274.62M	P/S	-	EPS this Y	-8.44%	Inst Trans	22.99%	Short Ratio	10.58	Perf Half Y	53.83%
Sales	0.00M	P/B	5.04	EPS next Y	-18.22%	ROA	-27.35%	Short Interest	9.49M	Perf YTD	12.08%
Book/sh	16.77	P/C	6.01	EPS next 5Y	-16.12%	ROE	-28.47%	52W High	95.32 -11.24%	Perf Year	126.87%
Cash/sh	14.07	P/FCF	-	EPS past 3/5Y	-75.11% -	ROIC	-21.78%	52W Low	34.34 146.36%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.77% 4.12%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-30.45%	Oper. Margin	-	ATR (14)	3.73	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	32.59	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.15	Recom	1.24
Dividend Gr. 3/5Y	- -	Current Ratio	32.59	EPS Q/Q	-11.87%	SMA20	-1.93%	Beta	0.68	Target Price	118.38
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	5.17%	Rel Volume	1.00	Prev Close	83.03
Employees	261	LT Debt/Eq	0.00	Earnings	Mar 02 BMO	SMA200	33.97%	Avg Volume	897.15K	Price	84.60
IPO	Jul 14, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.76% -	Trades		Volume	896,549	Change	1.89%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)